Inventor · disambiguated record
Jasbir Singh
Also filed as: SINGH JASBIR
48 granted patents·19 pending applications·568 citations·filing 1987–2021
98Inventor score
Top patents by PatentIndex Score
67 records- 0194US8957066B2Histone deacetylase inhibitorsREPLIGEN CORP·Filed 2013·Granted Feb 17, 2015·20 cites·13 claims
- 0293US9512143B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2015·Granted Dec 6, 2016·11 cites·18 claims
- 0393US7074793B2Cyclic substituted fused pyrrolocarbazoles and isoindolonesCEPHALON INC·Filed 2004·Granted Jul 11, 2006·60 cites·25 claims
- 0493US6455525B1Heterocyclic substituted pyrazolonesCEPHALON INC·Filed 2000·Granted Sep 24, 2002·63 cites·20 claims
- 0592US7674802B2N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammationDECODE GENETICS EHF·Filed 2006·Granted Mar 9, 2010·10 cites·8 claims
- 0692US6359130B1Bridged indenopyrrolocarbazolesCEPHALON INC·Filed 2000·Granted Mar 19, 2002·48 cites·14 claims
- 0789US9908899B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Mar 6, 2018·5 cites·24 claims
- 0889US5256657ASuccinamide derivative matrix-metalloprotease inhibitorsSTERLING WINTHROP INC·Filed 1991·Granted Oct 26, 1993·48 cites·11 claims
- 0987US5585357AHeteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitorsSANOFI WINTHROP INC·Filed 1996·Granted Dec 17, 1996·69 cites·24 claims
- 1086US9540395B2Histone deacetylase inhibitorsJACQUES VINCENT·Filed 2012·Granted Jan 10, 2017·9 cites·26 claims
- 1186US7750012B2Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammationDECODE GENETICS EHF·Filed 2006·Granted Jul 6, 2010·9 cites·23 claims
- 1285US7402684B2Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammationDECODE GENECTICS EHF·Filed 2006·Granted Jul 22, 2008·15 cites·29 claims
- 1383US11021514B2CompoundsATHIRA PHARMA INC·Filed 2017·Granted Jun 1, 2021·3 cites·38 claims
- 1483US7648978B2Small molecule modulators of cytokine activityANGION BIOMEDICA CORP·Filed 2005·Granted Jan 19, 2010·6 cites·32 claims
- 1581US6127401ABridged indenopyrrolocarbazolesCEPHALON INC·Filed 1999·Granted Oct 3, 2000·49 cites·39 claims
- 1680US7598397B2Sulfonamide peri-substituted bicyclics for occlusive artery diseaseDECODE GENETICS EHF·Filed 2005·Granted Oct 6, 2009·4 cites·10 claims
- 1779US8791267B2Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersSINGH JASBIR·Filed 2012·Granted Jul 29, 2014·4 cites·22 claims
- 1876US7288650B2Cyclic substituted fused pyrrolocarbazoles and isoindolonesCEPHALON INC·Filed 2006·Granted Oct 30, 2007·2 cites·42 claims
- 1975US10059723B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Aug 28, 2018·1 cites·26 claims
- 2075US8338465B2Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosisSINGH JASBIR·Filed 2007·Granted Dec 25, 2012·4 cites·33 claims
- 2175US7888366B22,4-diaminoquinazolines for spinal muscular atrophyFAMILIES OF SPINAL MUSCULAR ATROPHY·Filed 2005·Granted Feb 15, 2011·2 cites·12 claims
- 2274US6841567B1Cyclic substituted fused pyrrolocarbazoles and isoindolonesCEPHALON INC·Filed 2000·Granted Jan 11, 2005·7 cites·36 claims
- 2373US8883833B2Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersSINGH JASBIR·Filed 2008·Granted Nov 11, 2014·1 cites·28 claims
- 2473US7985755B22,4-diaminoquinazolines for spinal muscular atrophyFAMILIES OF SPINAL MUSCULAR ATROPHY·Filed 2007·Granted Jul 26, 2011·2 cites·53 claims
- 2572US2020148704A1Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2019·Application pending·0 cites
- 2670US6831075B2Heterocyclic substituted pyrazolonesCEPHALON INC·Filed 2002·Granted Dec 14, 2004·4 cites·29 claims
- 2770US5843905APeptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Dec 1, 1998·15 cites·8 claims
- 2869US10301323B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted May 28, 2019·0 cites·14 claims
- 2969US5677283Aα-heteroaryloxymethyl ketones as interleukin - 1 β converting enzyme inhibitorsSANOFI SA·Filed 1996·Granted Oct 14, 1997·26 cites·3 claims
- 3069US4839465ADi-(D-tryptophyl and/or tetrahydropyridoindolylcarbonyl)-containing peptide amides and process for preparation thereofSTERLING DRUG INC·Filed 1987·Granted Jun 13, 1989·21 cites·18 claims
- 3167US10280182B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted May 7, 2019·0 cites·10 claims
- 3267US8598359B2Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammationSANDANAYAKA VINCENT·Filed 2008·Granted Dec 3, 2013·1 cites·13 claims
- 3367US5985838APeptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1996·Granted Nov 16, 1999·8 cites·11 claims
- 3465US10981933B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2019·Granted Apr 20, 2021·0 cites·16 claims
- 3565US10077260B2Read-through compound prodrugs suppressing premature nonsense mutationsUNIV CALIFORNIA·Filed 2015·Granted Sep 18, 2018·1 cites·25 claims
- 3665US7579483B2Process for preparing 7-(acryloyl)indolesDECODE GENETICS EHF·Filed 2007·Granted Aug 25, 2009·1 cites·30 claims
- 3765US2009136473A1Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disordersDECODE GENETICS EHF·Filed 2008·Application pending·0 cites
- 3864US10526346B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted Jan 7, 2020·0 cites·14 claims
- 3964US6576614B1Peptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1999·Granted Jun 10, 2003·7 cites·9 claims
- 4064US2009324569A1Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disordersDECODE GENETICS EHF·Filed 2008·Application pending·0 cites
- 4163US5378803AAzole-fused peptides and processes for preparation thereofSTERLING WINTHROP INC·Filed 1992·Granted Jan 3, 1995·21 cites·34 claims
- 4262US12421276B2Methods of treating neurodegenerative disease with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analoguesATHIRA PHARMA INC·Filed 2021·Granted Sep 23, 2025·0 cites·57 claims
- 4361US2010137285A1Small molecule modulators of cytokine activityANGION BIOMEDICA CORP·Filed 2009·Application pending·0 cites
- 4461US2014301999A1Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disordersDECODE GENETICS EHF·Filed 2014·Application pending·0 cites
- 4560US2009291948A1Sulfonamide peri-substituted bicyclics for occlusive artery diseaseDECODE GENETICS EHF·Filed 2009·Application pending·0 cites
- 4659US7576102B2Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammationDECODE GENETICS EHF·Filed 2006·Granted Aug 18, 2009·0 cites·11 claims
- 4758US2009233969A1Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammationDECODE GENETICS EHF·Filed 2009·Application pending·0 cites
- 4858US2009075985A1Aryl sulfonamide peri-substituted bicyclics for occlusive artery diseaseDECODE GENETICS INC·Filed 2008·Application pending·0 cites
- 4957US2012213758A1Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disordersSINGH JASBIR·Filed 2012·Application pending·0 cites
- 5057US2014275553A1Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disordersDECODE GENETICS EHF·Filed 2014·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jasbir Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →